DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,978 filers reported holding DANAHER CORPORATION in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,877,753,356 | +3.4% | 55,936,128 | +0.0% | 0.34% | +7.2% |
| Q2 2023 | $13,420,180,560 | -3.4% | 55,917,419 | +1.5% | 0.32% | -10.2% |
| Q1 2023 | $13,889,547,348 | -3.9% | 55,108,504 | +1.2% | 0.35% | -9.9% |
| Q4 2022 | $14,446,426,538 | +4.2% | 54,428,553 | +1.4% | 0.39% | -3.7% |
| Q3 2022 | $13,867,623,000 | +3.8% | 53,690,131 | +1.9% | 0.41% | +8.5% |
| Q2 2022 | $13,359,142,000 | -10.7% | 52,694,630 | +3.3% | 0.38% | +6.2% |
| Q1 2022 | $14,961,250,000 | -9.0% | 51,004,840 | +2.1% | 0.35% | -5.1% |
| Q4 2021 | $16,437,401,000 | +8.6% | 49,960,190 | +0.4% | 0.37% | -0.8% |
| Q3 2021 | $15,141,853,000 | +14.3% | 49,736,739 | +0.7% | 0.38% | +13.9% |
| Q2 2021 | $13,248,776,000 | +19.9% | 49,369,413 | +0.6% | 0.33% | +10.4% |
| Q1 2021 | $11,051,096,000 | +2.1% | 49,098,533 | +0.7% | 0.30% | -4.8% |
| Q4 2020 | $10,827,032,000 | +2.4% | 48,739,681 | -0.8% | 0.31% | -10.3% |
| Q3 2020 | $10,577,515,000 | +20.3% | 49,122,337 | -1.2% | 0.35% | +12.2% |
| Q2 2020 | $8,793,659,000 | +24.8% | 49,729,454 | -2.3% | 0.31% | +4.0% |
| Q1 2020 | $7,045,249,000 | -7.2% | 50,901,306 | +2.9% | 0.30% | +15.8% |
| Q4 2019 | $7,589,427,000 | +7.0% | 49,448,957 | +0.7% | 0.26% | -1.5% |
| Q3 2019 | $7,092,407,000 | +2.8% | 49,106,189 | +1.7% | 0.26% | +1.2% |
| Q2 2019 | $6,897,635,000 | +9.8% | 48,262,218 | +1.4% | 0.26% | +5.7% |
| Q1 2019 | $6,280,956,000 | +32.0% | 47,575,797 | +3.1% | 0.25% | +15.0% |
| Q4 2018 | $4,758,941,000 | -2.1% | 46,149,541 | +3.2% | 0.21% | +12.6% |
| Q3 2018 | $4,861,338,000 | +11.6% | 44,738,984 | +1.4% | 0.19% | +4.4% |
| Q2 2018 | $4,355,139,000 | +2.2% | 44,133,966 | +1.4% | 0.18% | -2.2% |
| Q1 2018 | $4,259,527,000 | +7.4% | 43,504,519 | +1.8% | 0.19% | +7.5% |
| Q4 2017 | $3,965,755,000 | +9.7% | 42,725,220 | +1.3% | 0.17% | +2.4% |
| Q3 2017 | $3,616,478,000 | +3.3% | 42,159,915 | +1.6% | 0.17% | -1.7% |
| Q2 2017 | $3,501,206,000 | -0.1% | 41,488,407 | +1.3% | 0.17% | -4.4% |
| Q1 2017 | $3,503,962,000 | +14.1% | 40,967,631 | +3.9% | 0.18% | +5.3% |
| Q4 2016 | $3,069,824,000 | +1.4% | 39,437,616 | +2.1% | 0.17% | -3.9% |
| Q3 2016 | $3,027,292,000 | -18.3% | 38,618,348 | +5.3% | 0.18% | -22.6% |
| Q2 2016 | $3,704,126,000 | +11.3% | 36,674,510 | +4.5% | 0.23% | +6.5% |
| Q1 2016 | $3,328,426,000 | +5.2% | 35,087,759 | +3.0% | 0.22% | +1.4% |
| Q4 2015 | $3,164,477,000 | -47.7% | 34,070,601 | -56.0% | 0.21% | -5.8% |
| Q3 2015 | $6,052,350,000 | +108.9% | 77,496,355 | +128.9% | 0.23% | +15.3% |
| Q2 2015 | $2,897,587,000 | +2.4% | 33,854,262 | +1.6% | 0.20% | +2.1% |
| Q1 2015 | $2,829,691,000 | +2.9% | 33,329,696 | +3.9% | 0.19% | -3.0% |
| Q4 2014 | $2,750,678,000 | +16.8% | 32,092,842 | +3.5% | 0.20% | +7.6% |
| Q3 2014 | $2,356,022,000 | -0.8% | 31,008,455 | +2.8% | 0.18% | -1.6% |
| Q2 2014 | $2,375,176,000 | +7.3% | 30,168,636 | +2.2% | 0.19% | +0.5% |
| Q1 2014 | $2,212,872,000 | -0.2% | 29,504,977 | +2.7% | 0.19% | -4.6% |
| Q4 2013 | $2,217,830,000 | +13.4% | 28,728,359 | +1.9% | 0.20% | +2.1% |
| Q3 2013 | $1,955,116,000 | +13.3% | 28,204,212 | +3.5% | 0.19% | +5.5% |
| Q2 2013 | $1,725,304,000 | – | 27,255,984 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |